NCT02065362 2026-01-29TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPCBaylor College of MedicinePhase 1 Active not recruiting14 enrolled
NCT02937272 2025-10-20A Study of LY3200882 in Participants With Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting223 enrolled